265 related articles for article (PubMed ID: 18183502)
21. CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia.
Lavabre-Bertrand T; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Fégueux N; Poncelet P; Rousset T; Taïb J; Emberger JM; Navarro M
Leuk Lymphoma; 1994 Mar; 13(1-2):89-94. PubMed ID: 7517747
[TBL] [Abstract][Full Text] [Related]
22. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
Dunphy CH; Wheaton SE; Perkins SL
Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
[TBL] [Abstract][Full Text] [Related]
23. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).
Horny HP; Sotlar K; Stellmacher F; Valent P; Grabbe J
J Clin Pathol; 2006 Mar; 59(3):264-8. PubMed ID: 16505276
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
Sarfati M; Fournier S; Christoffersen M; Biron G
Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
[TBL] [Abstract][Full Text] [Related]
25. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
Roliński J; Rupniewska ZM; Wasik-Szczepanek E
Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
[TBL] [Abstract][Full Text] [Related]
26. Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies.
Orazi A; Cattoretti G; Polli N; Delia D; Rilke F
Eur J Haematol; 1991 Jul; 47(1):28-35. PubMed ID: 1714406
[TBL] [Abstract][Full Text] [Related]
27. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
29. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
30. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
[TBL] [Abstract][Full Text] [Related]
31. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts.
Fournier S; Tran ID; Suter U; Biron G; Delespesse G; Sarfati M
Leuk Res; 1991; 15(7):609-18. PubMed ID: 1830631
[TBL] [Abstract][Full Text] [Related]
32. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
Dorfman DM; Pinkus GS
Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
34. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
35. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen.
Lampert IA; Wotherspoon A; Van Noorden S; Hasserjian RP
Hum Pathol; 1999 Jun; 30(6):648-54. PubMed ID: 10374772
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia with low lymphocyte count.
Batata A; Shen B
Cancer; 1993 May; 71(9):2732-8. PubMed ID: 7682147
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
39. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia.
Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M
Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388
[TBL] [Abstract][Full Text] [Related]
40. A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL.
Salomon-Nguyen F; Valensi F; Merle-Beral H; Flandrin G
Leuk Lymphoma; 1995 Feb; 16(5-6):445-50. PubMed ID: 7540458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
